Injection-site irritation is redness, warmth, or itch confined to the needle entry point, appearing minutes to hours afterward, while systemic pruritus is generalized itching across the body that can begin days into treatment or with dose escalation
Autophagy 17 , 28562875 (2021)
Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders
Benefits include improved sleep quality, enhanced recovery, better body composition, and reduced visceral fat, all of which indirectly support testosterone levels
Why is the semaglutide segment dominant in the GLP-1 receptor agonist industry
This is where well discuss your goals and assess the areas you want to treat
